Photodynamic Therapy of Acne

Chapter

Abstract

Topical therapies may be used for treating mild to moderate acne. In the recent years, antibiotics, especially tetracyclines, have been used for the treatment of acne. For very severe cases, isotretinoin is still probably the therapy of choice. Photodynamic therapy (PDT) may be an alternative to antibiotic treatment in selected cases. However, the exact treatment scheme is not established yet. We know neither the relevant concentration of the prodrug nor the proper intensity of the light or the total light dose. PDT may be used in selected cases, but much more research has to be done before PDT of acne can be used in routine clinical practice.

Keywords

Placebo Peroxide Porphyrin Tetracycline Triglyceride 

References

  1. 1.
    Sigurdsson V, Knulst AC, van Weelden H. Phototherapy of acne vulgaris with visible light. Dermatology. 1997;194:256–60.PubMedCrossRefGoogle Scholar
  2. 2.
    Leyden JJ, McGinley K, Mills OH, et al. Topical antibiotics and topical antimicrobial agents in acne therapy. Acta Derm Venereol Suppl (Stockh). 1980;Suppl 89:75–82.Google Scholar
  3. 3.
    Leyden JJ, Shalita AR. Rational therapy for acne vulgaris: an update on topical treatment. J Am Acad Dermatol. 1986;15:907–15.PubMedCrossRefGoogle Scholar
  4. 4.
    Leyden JJ, McGinley KJ, Cavalieri S, et al. Propionibacterium acnes resistance to antibiotics in acne patients. J Am Acad Dermatol. 1983;8:41–5.PubMedCrossRefGoogle Scholar
  5. 5.
    Oprica C, Emtestam L, Lapins J, et al. Antibiotic-resistant Propionibacterium acnes on the skin of patients with moderate to severe acne in Stockholm. Anaerobe. 2004;10:155–64.PubMedCrossRefGoogle Scholar
  6. 6.
    Eady EA, Gloor M, Leyden JJ. Propionibacterium acnes resistance: a worldwide problem. Dermatology. 2003;206:54–6.PubMedCrossRefGoogle Scholar
  7. 7.
    Batt AL, Bruce IB, Aga DS. Evaluating the vulnerability of surface waters to antibiotic contamination from varying wastewater treatment plant discharges. Environ Pollut. 2006;142:295–302.PubMedCrossRefGoogle Scholar
  8. 8.
    Kong WD, Zhu YG, Fu BJ, et al. The veterinary antibiotic oxytetracycline and Cu influence functional diversity of the soil microbial community. Environ Pollut. 2006;143:129–37.PubMedCrossRefGoogle Scholar
  9. 9.
    Pillsbury DM, Shelly WB, Kligman A. A manual of cutaneous medicine, vol. 1. Philadelphia: WB Saunders; 1961.Google Scholar
  10. 10.
    O’Brien SC, Lewis JB, Cunliffe WJ. The Leeds revised acne grading system. J Dermatol Treat. 1998;9:215–20.CrossRefGoogle Scholar
  11. 11.
    Eady EA, Cove JH. Is acne an infection of blocked pilosebaceous follicles? Implications for antimicrobial treatment. Am J Clin Dermatol. 2000;1:201–9.PubMedCrossRefGoogle Scholar
  12. 12.
    Cunliffe WJ, Holland DB, Jeremy A. Comedone formation: etiology, clinical presentation, and treatment. Clin Dermatol. 2004;22:367–74.PubMedCrossRefGoogle Scholar
  13. 13.
    Tan HH. Topical antibacterial treatments for acne vulgaris: comparative review and guide to selection. Am J Clin Dermatol. 2004;5:79–84.PubMedCrossRefGoogle Scholar
  14. 14.
    Tappeiner H, Jesionek A. Therapeutische versuche mit fluoreszierenden stoffen. Münch Med Wochenschr. 1903;47:2042–4.Google Scholar
  15. 15.
    Divaris DX, Kennedy JC, Pottier RH. Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence. Am J Pathol. 1990;136:891–7.PubMedGoogle Scholar
  16. 16.
    Peng Q, Soler AM, Warloe T, et al. Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate. J Photochem Photobiol B. 2001;62:140–5.PubMedCrossRefGoogle Scholar
  17. 17.
    Sandberg C, Halldin CB, Ericson MB, et al. Bioavailability of aminolaevulinic acid and methylaminolaevulinate in basal cell carcinomas: a perfusion study using microdialysis in vivo. Br J Dermatol. 2008;159:1170–6.PubMedGoogle Scholar
  18. 18.
    Ericson MB, Sandberg C, Stenquist B, et al. Photodynamic therapy of actinic keratosis at varying fluence rates: assessment of photobleaching, pain and primary clinical outcome. Br J Dermatol. 2004;151: 1204–12.PubMedCrossRefGoogle Scholar
  19. 19.
    Ashkenazi H, Malik Z, Harth Y, et al. Eradication of Propionibacterium acnes by its endogenic porphyrins after illumination with high intensity blue light. FEMS Immunol Med Microbiol. 2003;35:17–24.PubMedCrossRefGoogle Scholar
  20. 20.
    Redondo P, Marquina M, Pretel M, et al. Methyl-ALA-induced fluorescence in photodynamic diagnosis of basal cell carcinoma prior to Mohs micrographic surgery. Arch Dermatol. 2008;144:115–7.PubMedCrossRefGoogle Scholar
  21. 21.
    Cunliffe WJ, Goulden V. Phototherapy and acne vulgaris. Br J Dermatol. 2000;142:855–6.PubMedCrossRefGoogle Scholar
  22. 22.
    Hongcharu W, Taylor CR, Chang Y, et al. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol. 2000;115:183–92.PubMedCrossRefGoogle Scholar
  23. 23.
    Pollock B, Turner D, Stringer MR, et al. Topical aminolaevulinic acid-photodynamic therapy for the treatment of acne vulgaris: a study of clinical efficacy and mechanism of action. Br J Dermatol. 2004;151:616–22.PubMedCrossRefGoogle Scholar
  24. 24.
    Wiegell SR, Wulf HC. Photodynamic therapy of acne vulgaris using 5-aminolevulinic acid versus methyl aminolevulinate. J Am Acad Dermatol. 2006;54:647–51.PubMedCrossRefGoogle Scholar
  25. 25.
    Horfelt C, Funk J, Frohm-Nilsson M, et al. Topical methyl aminolaevulinate photodynamic therapy for treatment of facial acne vulgaris: results of a randomized, controlled study. Br J Dermatol. 2006;155: 608–13.PubMedCrossRefGoogle Scholar
  26. 26.
    Horfelt C, Stenquist B, Larko O, et al. Photodynamic therapy for acne vulgaris: a pilot study of the dose-response and mechanism of action. Acta Derm Venereol. 2007;87:325–9.PubMedCrossRefGoogle Scholar
  27. 27.
    Mills OH, Porte M, Kligman AM. Enhancement of comedogenic substances by ultraviolet radiation. Br J Dermatol. 1978;98:145–50.PubMedCrossRefGoogle Scholar
  28. 28.
    Papageorgiou P, Katsambas A, Chu A. Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris. Br J Dermatol. 2000;142:973–8.PubMedCrossRefGoogle Scholar
  29. 29.
    Sadick NS. Handheld LED array device in the treatment of acne vulgaris. J Drugs Dermatol. 2008;7:347–50.PubMedGoogle Scholar
  30. 30.
    Horfelt C, Stenquist B, Halldin CB, et al. Single low-dose red light is as efficacious as methyl-aminolevulinate–photodynamic therapy for treatment of acne: clinical assessment and fluorescence monitoring. Acta Derm Venereol. 2009;89:372–8.PubMedCrossRefGoogle Scholar
  31. 31.
    Skiveren J, Haedersdal M, Philipsen PA, et al. Morphine gel 0.3% does not relieve pain during topical photodynamic therapy: a randomized, double-blind, placebo-controlled study. Acta Derm Venereol. 2006;86:409–11.PubMedCrossRefGoogle Scholar
  32. 32.
    Sandberg C, Stenquist B, Rosdahl I, et al. Important factors for pain during photodynamic therapy for actinic keratosis. Acta Derm Venereol. 2006;86: 404–8.PubMedCrossRefGoogle Scholar
  33. 33.
    Holmes MV, Dawe RS, Ferguson J, et al. A randomized, double-blind, placebo-controlled study of the efficacy of tetracaine gel (Ametop) for pain relief during topical photodynamic therapy. Br J Dermatol. 2004;150:337–40.PubMedCrossRefGoogle Scholar
  34. 34.
    Langan SM, Collins P. double-blind, placebo-controlled prospective study of the efficacy of topical anaesthesia with a eutetic mixture of lignocaine 2.5% and prilocaine 2.5% for topical 5-aminolaevulinic acid-photodynamic therapy for extensive scalp actinic keratoses. Br J Dermatol. 2006;154:146–9.PubMedCrossRefGoogle Scholar
  35. 35.
    Grapengiesser S, Ericson M, Gudmundsson F, et al. Pain caused by photodynamic therapy of skin cancer. Clin Exp Dermatol. 2002;27:493–7.PubMedCrossRefGoogle Scholar
  36. 36.
    Wiegell SR, Skiveren J, Philipsen PA, et al. Pain during photodynamic therapy is associated with protoporphyrin IX fluorescence and fluence rate. Br J Dermatol. 2008;158:727–33.PubMedCrossRefGoogle Scholar
  37. 37.
    Borelli C, Herzinger T, Merk K, et al. Effect of subcutaneous infiltration anesthesia on pain in photodynamic therapy: a controlled open pilot trial. Dermatol Surg. 2007;33:314–8.PubMedCrossRefGoogle Scholar
  38. 38.
    Paoli J, Halldin C, Ericson MB, et al. Nerve blocks provide effective pain relief during topical photodynamic therapy for extensive facial actinic keratoses. Clin Exp Dermatol. 2008;33:559–64.PubMedCrossRefGoogle Scholar
  39. 39.
    Halldin CB, Paoli J, Sandberg C, et al. Nerve blocks enable adequate pain relief during topical photodynamic therapy of field cancerization on the forehead and scalp. Br J Dermatol. 2009;160:795–800.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Department of DermatologySahlgrenska University HospitalGothenburgSweden

Personalised recommendations